B. Metzler seel. Sohn & Co. Holding AG Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 69,339 shares of the company's stock, valued at approximately $5,675,000. B. Metzler seel. Sohn & Co. Holding AG owned 0.08% of HealthEquity at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Swiss National Bank lifted its position in shares of HealthEquity by 0.4% during the 3rd quarter. Swiss National Bank now owns 169,900 shares of the company's stock valued at $13,906,000 after acquiring an additional 600 shares during the period. Thrivent Financial for Lutherans grew its stake in shares of HealthEquity by 33.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company's stock worth $24,033,000 after acquiring an additional 73,404 shares in the last quarter. RiverPark Advisors LLC bought a new stake in shares of HealthEquity in the 3rd quarter worth $230,000. Mutual of America Capital Management LLC grew its position in HealthEquity by 0.7% during the third quarter. Mutual of America Capital Management LLC now owns 97,718 shares of the company's stock valued at $7,998,000 after buying an additional 648 shares during the period. Finally, Vaughan Nelson Investment Management L.P. grew its position in HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock valued at $69,034,000 after buying an additional 226,563 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the business's stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company's stock, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the business's stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now directly owns 4,823 shares in the company, valued at $387,093.98. This trade represents a 20.54 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. The Goldman Sachs Group started coverage on shares of HealthEquity in a report on Friday, November 15th. They set a "neutral" rating and a $108.00 price objective on the stock. Barrington Research restated an "outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th. Bank of America increased their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a research report on Wednesday, November 13th. Deutsche Bank Aktiengesellschaft increased their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Finally, BTIG Research lifted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research note on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $107.23.

HealthEquity Stock Up 0.3 %

Shares of HealthEquity stock traded up $0.29 during trading on Wednesday, hitting $102.96. 772,678 shares of the stock traded hands, compared to its average volume of 625,582. The firm has a market cap of $8.99 billion, a P/E ratio of 85.80, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $103.69. The stock's fifty day simple moving average is $86.66 and its 200 day simple moving average is $81.57.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. On average, equities analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.